Clarivate (NYSE:CLVT) Trading 7.2% Higher – Here’s Why

Clarivate PLC (NYSE:CLVT) traded up 7.2% during trading on Monday . The stock traded as high as $2.56 and last traded at $2.5950. 408,122 shares were traded during trading, a decline of 94% from the average session volume of 6,594,377 shares. The stock had previously closed at $2.42.

Analyst Ratings Changes

CLVT has been the topic of a number of research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Clarivate in a research note on Friday, March 27th. Citigroup cut their price target on Clarivate from $4.25 to $2.80 and set a “neutral” rating on the stock in a research report on Wednesday, March 4th. Wall Street Zen upgraded Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Barclays lowered their target price on Clarivate from $4.00 to $2.40 and set an “underweight” rating on the stock in a research note on Wednesday, February 25th. Finally, Royal Bank Of Canada dropped their target price on Clarivate from $5.00 to $3.00 and set a “sector perform” rating on the stock in a report on Wednesday, February 25th. Five research analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, Clarivate presently has a consensus rating of “Reduce” and a consensus price target of $3.22.

Clarivate Trading Up 6.0%

The stock has a market cap of $1.64 billion, a PE ratio of -12.21 and a beta of 1.41. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.84 and a current ratio of 0.84. The company has a 50 day moving average of $2.54 and a two-hundred day moving average of $2.88.

Clarivate (NYSE:CLVT) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.04. The company had revenue of $585.50 million for the quarter, compared to the consensus estimate of $569.50 million. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.Clarivate’s revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.14 earnings per share. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Sell-side analysts anticipate that Clarivate PLC will post 0.65 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Clarivate

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. M&T Bank Corp acquired a new stake in shares of Clarivate in the fourth quarter valued at about $34,000. Essex Financial Services Inc. acquired a new stake in Clarivate in the 3rd quarter worth about $41,000. PharVision Advisers LLC acquired a new stake in Clarivate in the 3rd quarter worth about $45,000. Personal CFO Solutions LLC purchased a new stake in Clarivate during the 1st quarter worth approximately $30,000. Finally, FreeGulliver LLC acquired a new position in shares of Clarivate during the first quarter valued at approximately $30,000. 85.72% of the stock is owned by hedge funds and other institutional investors.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.